Progresses in clinical studies on antiviral therapies for COVID‐19—Experience and lessons in design of clinical trials

Antiviral therapy with antiviral agents is a very important component of treatment for the 2019 novel coronavirus disease (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). It is important to clarify how to evaluate efficacy and safety of antiviral agents in treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhaori, Getu, Lu, Lu, Liu, Chunyan, Guo, Yongli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768300/
https://www.ncbi.nlm.nih.gov/pubmed/33376954
http://dx.doi.org/10.1002/ped4.12227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768300/
https://www.ncbi.nlm.nih.gov/pubmed/33376954
http://dx.doi.org/10.1002/ped4.12227

Ejemplares similares